(Univariate Analysis) | Multivariate analysis | |||||||
---|---|---|---|---|---|---|---|---|
PsA+VTE | P value | HR | 95% CI | P value | HR | 95% CI | ||
Age (Mean± SD, Median) | 65.2±12.3 | <0.0001 | 1.08 | 1.06-1.10 | <0.0001 | 1.08 | 1.05-1.11 | |
sex | Female | 39/2807 (1.4%) | 0.11 | 1.53 | 0.91-2.55 | 0.34 | 1.32 | 0.75-2.30 |
Male | 23/2468 (0.9%) | Ref. | ||||||
Socio-economic statusa | 1-low | 21/1621 (1.3%) | Ref. | 0.32 | 0.74 | 0.41-1.34 | ||
2-medium | 25/2043 (1.2%) | 0.75 | 0.91 | 0.51-1.63 | 0.22 | 0.65 | 0.33-1.29 | |
3-high | 15/1326 (1.1%) | 0.61 | 0.84 | 0.43-1.63 | ||||
BMIa | BMI<25 | 13/1480 (0.9%) | Ref. | |||||
BMI≧25<30 | 20/1795 (1.1%) | 0.67 | 1.16 | 0.58-2.34 | 0.46 | 0.77 | 0.37-1.57 | |
BMI≧30 | 28/1765 (.6%) | 0.09 | 1.76 | 0.91-3.40 | 0.99 | 0.99 | 0.48-2.09 | |
Tobacco use | Yes | 25/2227 (1.1%) | 0.82 | 0.94 | 0.57-1.56 | 0.90 | 0.97 | 0.56-1.66 |
No | 37/3048 (1.2%) | Ref. | ||||||
Psoriasis | Yes | 52/4244 (1.2%) | 0.92 | 1.04 | 0.53-2.04 | 0.23 | 0.73 | 0.43-1.22 |
No | 10/1031(0.97%) | Ref. | ||||||
Comorbidity | Cancer | |||||||
Yes | 8/337 (2.4%) | 0.011 | 2.64 | 1.25-5.54 | 0.50 | 1.30 | 0.61-2.81 | |
No | 54/4939 (1.1%) | Ref. | ||||||
Diabetes | 0.001 | |||||||
Yes | 29/1781 (1.6%) | 2.30 | 1.40-3.82 | 0.56 | 1.19 | 0.65-2.18 | ||
No | 33/3494 (0.9%) | Ref. | ||||||
IHD | ||||||||
Yes | 14/542 (2.6%) | 0.0004 | 2.93 | 1.62-5.32 | 0.81 | 1.09 | 0.53-2.25 | |
No | 48/4733 (1.0%) | Ref. | ||||||
CVA/TIA | 0.01 | |||||||
Yes | 6/234 (2.5%) | 2.99 | 1.28-6.95 | 0.69 | 1.22 | 0.47-3.15 | ||
No | 56/5032 (1.1%) | Ref. | ||||||
CHF | ||||||||
Yes | 4/117 (3.4%) | 0.001 | 5.97 | 2.15-16.60 | 0.31 | 1.88 | 0.55-6.41 | |
No | 58/5158 (1.1%) | Ref. | ||||||
Hypertension | ||||||||
Yes | 35/1589 (2.2%) | <0.0001 | 3.20 | 1.94-5.29 | 0.84 | 1.06 | 0.59-1.93 | |
No | 27/3686 (0.7%) | Ref. | ||||||
AF | ||||||||
Yes | 5/159 (3.1%) | 0.003 | 4.03 | 1.61-10.1 | 0.97 | 0.98 | 0.33-2.87 | |
No | 57/5116 (1.1%) | Ref. | ||||||
Vascular disease | ||||||||
Yes | 5/196 (2.6%) | 0.025 | 2.84 | 1.14-7.10 | 0.83 | 0.90 | 0.33-2.44 | |
No | 57/5079 (1.1%) | Ref. | ||||||
COPD | ||||||||
Yes | 6/465 (1.3%) | 0.55 | 1.30 | 0.56-3.00 | 0.77 | 0.88 | 0.37-2.08 | |
No | 56/4810 (1.2%) | Ref. | ||||||
CRF | ||||||||
Yes | 2/159 (1.3%) | 0.45 | 1.73 | 0.42-7.01 | 0.54 | 0.62 | 0.14-2.78 | |
No | 60/5116 (1.2%) | Ref. | ||||||
Past VTE | ||||||||
Yes | 7/36 (18.0%) | <0.0001 | 31.63 | 14.20-70.60 | <0.0001 | 19.60 | 8.37-45.94 | |
No | 55/5236 (1.1%) | Ref. | ||||||
Medication | cDMARD | Yes 46/3705 (1.2%) | 1.56 | 0.88-2.89 | 0.25 | 1.44 | 0.77-2.67 | |
No 16/1570 (1.0%) | 0.12 | Ref. | ||||||
bDMARD | Yes 19/1989 (1.0%) | 0.39 | 1.30 | 0.72-2.37 | 0.36 | 1.33 | 0.73-2.44 | |
No 43/3286 (1.3%) | Ref. |